Soleus Capital Management, L.P. Pep Gen Inc. Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.31 - $16.57 $1.12 Million - $1.99 Million	-120,000 Reduced 92.31%	10,000 $133,000
Q3 2022 Nov 14, 2022	SELL	$4.86 - $12.75 $218,700 - $573,750	-45,000 Reduced 25.71%	130,000 $1.18 Million
Q2 2022 Aug 15, 2022	BUY	$9.0 - $12.89 $1.58 Million - $2.26 Million	175,000 New	175,000 $1.74 Million

25.2M

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $85.8M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.